Biomeme
Host Response

Our Evidence

These studies show the impact and potential for host response diagnostics.

Host Response diagnostics have immense potential to save human lives and combat antimicrobial resistance by providing quick and predictive diagnoses. With its remarkable accuracy and efficiency, it could very well revolutionize global healthcare while also mitigating the effects of future pandemics.

We are hard at work to define and advance the full capabilities of host response diagnostics, but there is already a strong body of evidence of just how impactful this technology will be.

Smartphone displaying Viral Infection Detected next to the Franklin ISP device
Validation

The Evidence of Host Response Effectiveness

In 2021, Biomeme merged with Predigen, a spin-out from Duke University and a global leader in the development of host gene expression signatures for use as prognostic, diagnostic, and therapeutic monitoring tools. That merger was made with the intention of advancing host response diagnostics by combining Predigen's machine learning algorithms with Biomeme's portable molecular testing platform.

The mission of these two companies is trusted by some of the world's most respected organizations, such as Cross-Border Threat Screening, National Institutes of Health, and the Antibacterial Resistance Leadership Group, and heavily featured in highly trusted publications such as DHS Science and Technology.

But don't take our word for it; read these studies to see the potential impact of Biomeme's host response technology on the advancement of global health.

Research

Selected Host Response Studies

23 peer-reviewed publications spanning over a decade of host response research.

July 2021

The host transcriptional response to Candidemia is dominated by neutrophil activation and heme biosynthesis and supports novel diagnostic approaches.

View on PubMed
March 2021

A blood-based host gene expression assay for early detection of respiratory viral infection: an index-cluster prospective cohort study.

View on PubMed
Feb 2021

Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.

View on PubMed
Jan 2021

Validation of a host gene expression test for bacterial/viral discrimination in immunocompromised hosts.

View on PubMed
July 2020

Previously derived host gene expression classifiers identify bacterial and viral etiologies of acute febrile respiratory illness in a south Asian population.

View on PubMed
Oct 2019

Validation of a host response test to distinguish bacterial and viral respiratory infection.

View on PubMed
Aug 2019

Epithelial and airway secretion host response distinguishes bacterial and viral infections.

View on PubMed
April 2019

Host gene expression classifiers diagnose acute respiratory illness etiology.

View on PubMed
Oct 2018

Improved detection of bacterial and viral coinfection using host gene expression classification.

View on PubMed
March 2018

Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters.

View on PubMed
Feb 2018

A community approach to mortality prediction in sepsis via gene expression analysis.

View on PubMed
Dec 2017

A host-based RT-PCR gene expression signature to identify acute respiratory viral infection.

View on PubMed
March 2017

Performance of a host response gene expression classifier for detection of bacterial and viral infection in febrile children.

View on PubMed
July 2016

Host gene expression signatures for discriminating clinical outcomes of severe trauma: a multicenter study.

View on PubMed
Oct 2015

A community-based host gene expression analysis for diagnosis of respiratory viral vs. bacterial infection.

View on PubMed
March 2016

A genomic signature of influenza infection shows potential for presymptomatic detection, guiding early therapy, and monitoring clinical responses.

View on PubMed
Jan 2016

Transcriptomic analysis of the host response and innate resilience to Enterotoxigenic Escherichia coli infection in humans.

View on PubMed
Dec 2015

Potential cost-effectiveness of early identification of hospital-acquired infection in critically ill patients.

View on PubMed
Sep 2013

Broad range host response gene expression classifiers identify infecting organisms in humans.

View on PubMed
Jan 2013

Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans.

View on PubMed
Aug 2011

A genomic signature to rapidly identify influenza and differentiate from other respiratory infections.

View on PubMed
Jul 2010

Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans.

View on PubMed
Sep 2009

Classification of acute respiratory viral infections by host gene expression signatures.

View on PubMed

*Biomeme's HR-B/V Test is currently under development and is not approved/cleared by the FDA.

Body Language Decoded

Learn more about Biomeme's Host Response Test (HR-B/V).